News Nov 18, 2024 Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality… Read Now
Interview Jul 19, 2024 Expanding the Alimentiv Site Network: An Interview With Peter Westerveld The Alimentiv Site Network (ASN) is our worldwide network of gastrointestinal (GI) centers that collaborate with us. With an established global reputation for high-quality monitoring… Read Now
Article May 30, 2024 Alimentiv DDW 2024 Presentations If you’ve missed some of our lecture presentations and poster sessions, reach out for more information…. Read Now
Article Mar 19, 2024 Countdown to Discovery: Previewing the Upcoming GI Clinical Trial Conferences In 2024 Explore GI clinical trial conferences in 2024 with our curated roster of events. This chronological listing offers an overview of the most influential gatherings worldwide,… Read Now
Article Jan 10, 2024 Bayesian innovations to supplement open-label trials Clinical trials in Crohn’s Disease face additional complexity as biologics provide additional treatment options but may require combination treatments to reach optimal efficacy. A Phase… Read Now
Article Nov 9, 2023 2023 Size of the CRO Market We recently published a summary article on the size of the contract research market for the period of 2023 to 2028. We collated data from multiple sources…. Read Now
Article Oct 11, 2023 Ultimate Guide to Contract Research Organization Market Size Due to Contract Research Organizations’ (CROs) significant impact on drug development and healthcare advancements, understanding the size and future growth of the CRO Market is… Read Now
Article Oct 2, 2023 How Diversity Impacts Clinical Trials The lack of diversity in clinical trial populations has been a longstanding issue in the medical and research communities. While some researchers and advocates have… Read Now
